Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer
The document provides an update on an analysis of letrozole in operable HR-positive, HER2-negative breast cancer, noting the trial status as…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer
ClinicalTrials.gov update indicates a study on combining radiotherapy with new drugs for metastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Financial Toxicity in Breast Cancer Surgery
This entry notes a clinical trial at McMaster University investigating financial toxicity in breast cancer surgery. The trial is currently a…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer [NA]
This clinical trial update indicates a dose-escalation concomitant boost radiotherapy study for early breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy
This clinical trial is investigating real-time molecular analysis of breast cancer in patients receiving neoadjuvant chemotherapy and is cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
Clinical trial update from the Montreal Heart Institute describing efforts to identify and evaluate patients at risk of developing chemother…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)
A completed clinical trial studied how hepatic impairment affects palbociclib-associated myelosuppression in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer [Phase 1, Phase 2]
This document reports a Phase 1/2 trial of grapiprant plus eribulin for metastatic inflammatory breast cancer, which was terminated and whos…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients [Phase 3]
Phase 3 clinical trial comparing UTD2 plus capecitabine to capecitabine alone as adjuvant therapy for patients with non-pCR triple-negative …
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study [NA]
A feasibility study evaluating whether vocational rehabilitation can support breast cancer patients in returning to work.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Post-operative Radiation With IMRT in the Management of Stage IIB-III Breast Cancer [NA]
Completed clinical trial evaluating post-operative IMRT for stage IIB-III breast cancer, with results posted.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) [Phase 2]
Phase 2 clinical trial update (KePreSt) assessing the effects of ketorolac and pregabalin in early-stage, estrogen receptor-positive breast …
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating oral metronomic capecitabine in combination with pyrotinib for HER2-positive metastatic breast cancer that…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Evaluatıon of sympathetıc Nervous System fındıngs and theır relatıonshıp wıth Symptoms ın patıents wıth Breast Cancer Related Lymphedema
This entry notes the completed status of Marmara University's clinical trial evaluating sympathetic nervous system findings and their relati…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel [NA]
A clinical trial update indicates the study evaluating real-time pressure controllers to alleviate peripheral neuropathy symptoms in breast …
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Effect of Laughter Therapy on Breast Cancer Patients [NA]
This entry notes a registered clinical trial to evaluate laughter therapy for psychological well-being in breast cancer patients, which is n…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study
A real-world study from Hebei Medical University Fourth Hospital evaluating neratinib as extended adjuvant therapy for patients with HER2-po…
-
FDA approval · 2025-06-12FDA Approved: TALZENNA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TALZENNA (talazoparib) by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers
This clinical trial update describes EpCAM-targeted Surface-Enhanced Raman Spectroscopy nanotags for rapid evaluation of surgical margins an…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis [Phase 2]
Clinical trial update on DS-8201a (trastuzumab deruxtecan) for advanced breast cancer, including biomarker analyses, in a Phase 2 study.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This update covers a completed Phase 1/2 clinical trial evaluating Tinengotinib (TT-00420) as both monotherapy and in combination therapy fo…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
This clinical trial update from the University of Alabama at Birmingham describes a study evaluating multiple behavior interventions to impr…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Self-compression Mammography in Clinical Practice [NA]
The clinical trial evaluating self-compression mammography in routine breast cancer screening has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies [NA]
A completed clinical trial from the University of Virginia evaluating two exercise interventions in breast cancer patients undergoing cardio…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adherence to the Mediterranean Diet Among Women Attending Mammographic Screening
This clinical trial update describes a study evaluating adherence to the Mediterranean diet among women undergoing mammographic screening fo…